Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine
- 15 December 1991
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (17), 1662-1667
- https://doi.org/10.1016/0002-9149(91)90326-g
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Outcomes Movement — Will It Get Us Where We Want to Go?New England Journal of Medicine, 1990
- A Clinician's Guide to Cost-Effectiveness AnalysisAnnals of Internal Medicine, 1990
- How to Evaluate DrugsPublished by American Medical Association (AMA) ,1990
- An analysis of the cost effectiveness of the implantable defibrillator.Circulation, 1990
- Meta-analysis in medicine Where we are and where we want to goJournal of Clinical Epidemiology, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- A comparison of statistical methods for combining event rates from clinical trialsStatistics in Medicine, 1989
- A Method for Meta-Analysis of Epidemiological StudiesDrug Intelligence & Clinical Pharmacy, 1988
- Management of Acute DysuriaAnnals of Internal Medicine, 1985
- If Nothing Goes Wrong, Is Everything All Right?JAMA, 1983